Related Experiment Video
Updated: Jun 16, 2025

07:38
Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
917
The neuropathology of Self-Injurious Behavior: Studies using animal models
1University of Florida, Department of Psychology, Behavioral and Cognitive Neuroscience Program, Gainesville, FL 32611-2250, USA.
Brain Research
|August 20, 2024
Summary
Self-injurious behavior, common in neurodevelopmental and psychiatric disorders, may share biological and environmental causes. Animal models offer insights into stress responses and neurotransmitter systems, aiding potential treatments across diverse populations.
Area of Science:
- Neuroscience
- Behavioral Science
- Psychiatry
Background:
- Self-injurious behavior (SIB) is prevalent in neurodevelopmental disorders, often linked to behavioral reinforcement or sensory stimulation.
- SIB also occurs in psychiatric disorders, associated with emotional regulation and suicidal ideation.
- Animal models exhibit SIB under adverse conditions, yet research translation is limited.
Purpose of the Study:
- To review evidence for common mechanisms underlying SIB across neurodevelopmental disorders, psychiatric disorders, and animal models.
- To highlight the potential of animal models for understanding SIB as a cross-diagnostic behavioral phenotype.
- To explore how animal studies can inform therapeutic strategies.
Main Methods:
- Literature review synthesizing findings from human and animal studies on self-injurious behavior.
- Analysis of biological and environmental factors contributing to SIB vulnerability.
- Examination of neurotransmitter system involvement and potential pharmacotherapeutic targets.
Main Results:
- Common biological and environmental mechanisms contribute to SIB vulnerability across species and diagnostic categories.
- Individual differences in stress response and anxiety are implicated in SIB.
- Animal models reveal dysregulation in monoaminergic and glutamatergic systems.
Conclusions:
- Animal models are valuable for investigating SIB as a cross-diagnostic phenotype.
- Understanding shared mechanisms can lead to novel therapeutic interventions for SIB.
- Pharmacological targets identified in animal models may benefit diverse clinical populations.

